Artwork

Content provided by Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)

1:00:05
 
Share
 

Manage episode 404900212 series 3011973
Content provided by Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:

  • The science behind what is happening in the body that causes weight loss while on Ozempic
  • What it was like in the 1990s and 2000s believing in a drug for a problem that the rest of the industry (including her own company) had written off
  • How weight loss was actually a goal from the very start — not just a side effect of diabetes medication like you often read today!

Sponsors:


  continue reading

101 episodes

Artwork
iconShare
 
Manage episode 404900212 series 3011973
Content provided by Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ben Gilbert and David Rosenthal, Ben Gilbert, and David Rosenthal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor, and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:

  • The science behind what is happening in the body that causes weight loss while on Ozempic
  • What it was like in the 1990s and 2000s believing in a drug for a problem that the rest of the industry (including her own company) had written off
  • How weight loss was actually a goal from the very start — not just a side effect of diabetes medication like you often read today!

Sponsors:


  continue reading

101 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide